These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19152229)

  • 21. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confidence interval for rate ratio in a 2 x 2 table with structural zero: an application in assessing false-negative rate ratio when combining two diagnostic tests.
    Tang ML; Tang NS; Carey VJ
    Biometrics; 2004 Jun; 60(2):550-5; discussion 555. PubMed ID: 15180684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confidence intervals of effect size for paired studies.
    Wu J; Jiang G
    Biom J; 2007 Aug; 49(5):765-73. PubMed ID: 17634978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A score test for binary data with patient non-compliance.
    Branson M; Whitehead J
    Stat Med; 2003 Oct; 22(20):3115-32. PubMed ID: 14518018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous confidence intervals using ordinal effect measures for ordered categorical outcomes.
    Ryu E
    Stat Med; 2009 Nov; 28(25):3179-88. PubMed ID: 19691062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous confidence bands for nonlinear regression models with application to population pharmacokinetic analyses.
    Gsteiger S; Bretz F; Liu W
    J Biopharm Stat; 2011 Jul; 21(4):708-25. PubMed ID: 21516565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confidence interval construction for the difference between two correlated proportions with missing observations.
    Tang NS; Li HQ; Tang ML; Li J
    J Biopharm Stat; 2016; 26(2):323-38. PubMed ID: 25632882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On tests of rate ratio under standard inverse sampling.
    Tang ML; Liao YJ; Ng HK
    Comput Methods Programs Biomed; 2008 Mar; 89(3):261-8. PubMed ID: 18164512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confidence intervals and sample-size calculations for the sisterhood method of estimating maternal mortality.
    Hanley JA; Hagen CA; Shiferaw T
    Stud Fam Plann; 1996; 27(4):220-7. PubMed ID: 8875734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The score test for independence in R x C contingency tables with missing data.
    Lipsitz SR; Fitzmaurice GM
    Biometrics; 1996 Jun; 52(2):751-62. PubMed ID: 8672711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confidence intervals for a ratio of binomial proportions based on paired data.
    Bonett DG; Price RM
    Stat Med; 2006 Sep; 25(17):3039-47. PubMed ID: 16345058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sample-size calculations for studies with correlated ordinal outcomes.
    Kim HY; Williamson JM; Lyles CM
    Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size for testing difference between two proportions for the bilateral-sample design.
    Qiu SF; Tang NS; Tang ML; Pei YB
    J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient intermediate fine mapping: confidence set inference with likelihood ratio test statistic.
    Sinha R; Luo Y
    Genet Epidemiol; 2007 Dec; 31(8):922-36. PubMed ID: 17615574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.